The effectiveness of the antenatal examination algorithm for nonimmune hydrops fetalis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To evaluate the effectiveness of the antenatal examination algorithm for nonimmune hydrops fetalis. Materials and methods. The study included pregnant women with nonimmune hydrops fetalis delivered at the Center from 2015 to 2020 (n=45), and divided into two groups. Group 1 (prospective group from 2018 to 2020) included 30 pregnant women with nonimmune hydrops fetalis who were antenatally examined and, in some cases, received intrauterine treatment; group 2 (retrospective group from 2015 to 2018) consisted of 15 women who were not antenatally examined and did not receive intrauterine treatment. Pregnant women were selected by the perinatal council of the Center. Results. According to the examination protocol, in group 1 the etiology of nonimmune hydrops fetalis was antenatally determined in 83.3% (25/30) of cases and 16.7% (5/30) of cases were considered as idiopathic. In group 2 the etiology was established in 86.7% (13/15) of cases: it was determined in 60% (9/15) of cases antenatally (on the basis of fetal ultrasound), and in 26.7% (4/15) of cases postnatally. The live birth rate did not differ statistically between groups, namely 70% (21/30) in group 1 versus 73.3% (11/15) in group 2 (p=0.94). However, the neonatal mortality rate was statistically higher in the group where intrauterine treatment was not performed, namely 73.8% (8/11) versus 23.8% (5/21) (p=0.002). Thus, the overall survival in group 1 was 53.3% (16/30), while in group 2 it was 20% (3/15). Conclusion. The introduction of the examination protocol into clinical practice has led to an increase in the detection of the causes of nonimmune hydrops fetalis at the antenatal stage, especially in the cases not associated with fetal malformations.

Full Text

Restricted Access

About the authors

Faina Z. Kadyrberdieva

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: f_kadyrberdieva@oparina4.ru
postgraduate student

Roman G. Shmakov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
MD, professor of the Russian Academy of Sciences

Ekaterina L. Bokeriya

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_bokeriya@oparina4.ru
MD, professor, head of the department of pathology of newborn and premature babies

Kirill V. Kostyukov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: k_kostyukov@oparina4.ru
PhD, doctor of the Department of the functional diagnosis

Nana K. Tetruashvili

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: n_tetruashvili@oparina4.ru
MD, Head of the Department of pregnancy loss prevention and therapy

References

  1. Ota S., Sahara J., Mabuchi A., Yamamoto R., Ishii K., Mitsuda N. Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis. J. Obstet. Gynaecol. Res. 2015; 42(4): 385-91. https://dx.doi. org/10.1111/jog.12922.
  2. Mary E.N., Suneet P.C., Jodi S.D. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline No.7: nonimmune hydrops fetalis. Am. J. Obstet. Gynecol. 2015; 212(2): 127-39. https://dx.doi.org/10.1016/j.ajog.2014.12.018.
  3. Desilets V., De Bie I., Audibert F. No.36-investigation and management of nonimmune fetal hydrops. J. Obstet. Gynaecol. Can. 2018; 40(8): 1077-90. https:// dx.doi.org/10.1016/j.jogc.2017.12.011.
  4. Laterre M., Bernard P., Vikkula M., Sznajer Y. Improved diagnosis in nonimmune hydrops fetalis using a standardized algorithm. Prenat. Diagn. 2018; 38(5): 337-43. https://dx.doi.org/10.1002/pd.5243.
  5. Berry S.M., Stone J., Norton M.E., Johnson D., Berghella V. Fetal blood sampling. Am. J. Obstet. Gynecol. 2013; 209(3): 170-80. https://dx.doi.org/10.1016/j. ajog.2013.07.014.
  6. Bellini C., Donarini G., Paladini D., Calevo M.G., Bellini T., Ramenghi L.A., Hennekam R.C. Etiology of non-immune hydrops fetalis: An update. Am. J. Med. Genet. A. 2015; 167A(5): 1082-8. https://dx.doi.org/10.1002/ajmg.a.36988.
  7. Бокерия Е.Л., Беспалова Е.Д., Суратова О.Г. Фетальные органические тахиаритмии: опыт лечения. Анналы аритмологии. 2011; 2: 36-44.
  8. Беспалова Е.Д., Бокерия Е.Л. Перинатальный кардиологический скрининг. Методические рекомендации для врачей неонатологов, педиатров, акушеров-гинекологов, врачей функциональной диагностики. Бокерия Л.А., Володин Н.Н., ред. М.; 2010.
  9. Huhta J.C. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr. Cardiol. 2004; 25(3): 274-86. https://dx.doi.org/10.1007/ s00246-003-0591-3.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies